# Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology

> **NCT02702271** · NA · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 458 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** WATCHMAN FLX

## Key facts

- **NCT ID:** NCT02702271
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-07
- **Primary completion:** 2020-01-28
- **Final completion:** 2021-03-12
- **Target enrollment:** 458 (ACTUAL)
- **Last updated:** 2022-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02702271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02702271, "Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02702271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*